Spectral MD Wins Best Technology Award at Prestigious European Mediscience Awards in London
DALLAS – June 27, 2022 – (Newswire.com)
Spectral MD Holdings, Ltd. (AIM: SMD), a Dallas-based company, won Best Technology at the prestigious European Mediscience Awards held in London this month. Spectral MD develops optical medical devices with proprietary artificial intelligence (AI) algorithms for faster and more accurate treatment decisions in wound care.
The European Mediscience Awards are the largest annual gathering of private and public healthcare, biotechnology and life science companies in Europe. Each year the event attracts over 500 UK and European life science companies to showcase their outstanding achievements in the healthcare, biotech, pharmaceutical and life sciences sectors. (visit: www.mediscience-event.co.uk)
Spectral MD was admitted to trading on the AIM market of the London Stock Exchange in June 2021 and thus became eligible for the European Mediscience Awards.
Spectral MD won the Best Technology award for its DeepView™ wound imaging technology by a panel of experts from the healthcare, biotechnology and life sciences industries. The goal of DeepView™ technology is to provide a rapid assessment of wound healing for clinicians to assess physiological information not visible to the human eye. According to the organizers, the criteria for the winning technology must “be innovative, well-funded and capable of significant commercial success”.
Funding and technical assistance for the development of the DeepView™ Wound Imaging System is provided by the Biomedical Advanced Research and Development Authority (BARDA), within the Office of the Assistant Secretary for Preparedness and Response (ASPR) within the US Department of Health and Human Resources. Services (HSS). This program has received total funding commitments of approximately $93 million from ASPR/BARDA since 2013. In addition, financial support has also been provided by the US National Science Foundation (NSF), National Institute of Health (NIH) and the US Defense Health Agency (DHA) in support of the burning application for the company’s DeepView™ solution.
Wensheng Fan, CEO of Spectral MD, commented: “I was delighted to receive this award on behalf of the Spectral MD team. This award is a testament to the passion and hard work of the Spectral MD team and the fantastic technology we continue to develop. It is a great honor that we have been recognized so quickly, on an international stage at such a prestigious event, for our innovative technology.
“I would also like to thank our partners at ASPR/BARDA and other institutions who have been incredibly supportive in helping us advance the clinical and systemic development of DeepView™ wound imaging technology.”
This project was funded in whole or in part by federal funds from the Department of Health and Human Services; Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Authority, under contract number 75A50119C00033.
For more information about BARDA, see aspr.hhs.gov/.
An image of Spectral MD CEO Wensheng Fan receiving the award is available here:
Picture shows from left to right: Nina Hossain, awards presenter; Anne Hennecke, Managing Partner, MC Services AG; Wensheng Fan, CEO, Spectral MD Holdings Ltd (winner); and Nooman Haque, Head of Life Sciences and Healthcare, Silicon Valley Bank.
For more information, please contact:
Spectral MD Holdings, Ltd. investors.spectralmd.com
Wensheng Fan, CEO via Walbrook PR
Nils Windler, Chief Financial Officer
Walbrook PR Ltd (Media and Investor Relations) Tel: +44 (0)20 7933 8780 or [email protected]Paul McManus / Sam Allen
Alice Woodings Mobile: +44 (0)7980 541 893 / +44 (0)7502 558 258
+44 (0)7407 804 654
We are a dedicated team of forward thinkers striving to revolutionize wound care management by “Seeing the Unknown” ® with our DeepView™ Wound Imaging System.
press release department
Spectral MD Wins Best Technology Award